BioNTech and Pfizer will boost manufacturing capacity of their Covid-19 vaccine to 2.5 billion doses by the end of 2021, BioNTech said on March 30, as the company projected sales of nearly 10 billion euros ($11.7 billion) from the product during 2021.

Russia’s Sputnik V could be produced in western Europe for the first time after a deal to make the Covid-19 vaccine in Italy was signed by the RDIF sovereign wealth fund and Swiss-based pharmaceutical company Adienne.


Merck & Co. will help make rival Johnson & Johnson’s Covid-19 vaccine in order to boost the slower-than-promised production of the one-dose shot, U.S. President Joe Biden said on March 2.

The United States expects to roll out 3 to 4 million doses of Johnson & Johnson’s Covid-19 vaccine during the first week of March, pending authorization from the Food and Drug Administration, White House Covid-19 response coordinator Jeff Zients said on Feb. 24.


Merck & Co. Inc. was in talks with governments and companies to potentially help with manufacturing of Covid-19 vaccines that have been already authorized.

The Biden administration is exploring every option for increasing manufacturing of Johnson & Johnson’s Covid-19 vaccine, which is under regulatory review, and said on Feb. 5 that currently expected levels of early doses were less than hoped.

IPG Health Germany won the communications account around the new women’s health portfolio of pharmaceutical manufacturer DR. KADE Health Care.

Moderna Inc. proposed filling vials with additional doses of the Covid-19 vaccine to ease a crunch in manufacturing as the company approaches the manufacturing of almost a million doses a day.

Moderna Inc. asked the U.S. Food and Drug Administration for permission to fill the company’s Covid-19 vaccine vials with up to five additional doses to ease a crunch in manufacturing, CNBC reported.

Swiss drugmaker Novartis signed an initial agreement to provide manufacturing capacity for Pfizer and BioNTech’s Covid-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.